Maekawa I, Kawamura T, Miyake T, Nakamura M, Kurosawa M
Department of Internal Medicine, Asahikawa Municipal Hospital, Hokkaido, Japan.
Hokkaido Igaku Zasshi. 1989 Mar;64(2):105-9.
Although determination of the presence of antibodies to HTLV-1 in cerebro-spinal fluid (CSF) is very important for the diagnosis of HTLV-1-associated myelopathy (HAM), these antibodies in CSF have not yet been completely investigated so far in patients without overt HAM. We examined antibodies to HTLV-1 in CSF of leukemia patients who were infected with this virus via blood transfusion. All of 5 patients showed positive antibody titer, one of 5 patients was a patient with overt HAM. According to Western-blotting analysis in CSF, IgG p-19, 24 and 28 antibodies were positive in 4 patients without overt HAM, but IgM antibody was negative. In contrast, IgG antibodies as well as IgM p-24 antibody were positive in patients with overt HAM. These results suggest that further studies on antibodies to HTLV-1, especially on IgM antibody, in CSF of HTLV-1 infected patients with or without overt HAM may be helpful to better understanding of the mechanism on onset of HAM following blood transfusion.
尽管脑脊液(CSF)中抗人嗜T淋巴细胞病毒1型(HTLV-1)抗体的检测对于HTLV-1相关脊髓病(HAM)的诊断非常重要,但迄今为止,在没有明显HAM的患者中,脑脊液中的这些抗体尚未得到充分研究。我们检测了因输血感染该病毒的白血病患者脑脊液中的抗HTLV-1抗体。5例患者的抗体滴度均呈阳性,其中1例为明显HAM患者。根据脑脊液的蛋白质印迹分析,4例无明显HAM的患者IgG p-19、24和28抗体呈阳性,但IgM抗体为阴性。相比之下,明显HAM患者的IgG抗体以及IgM p-24抗体呈阳性。这些结果表明,对HTLV-1感染的有或无明显HAM患者的脑脊液中抗HTLV-1抗体,尤其是IgM抗体进行进一步研究,可能有助于更好地理解输血后HAM的发病机制。